PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
14-Aug-2023 Hospital and Clinical Pharmacy Preferred Distribution Channels for Blastomycosis Drugs: Market Insights and Regional Analysis - ResearchAndMarkets.com Businesswire
14-Aug-2023 2023 Global Allergy Treatment Market Forecasted to Grow with Increasing Prevalence of Allergies Worldwide - ResearchAndMarkets.com Businesswire
14-Aug-2023 Arcturus Therapeutics Joint Venture mRNA Manufacturing Partner, ARCALIS, Awarded $115 Million in Grants from the Japanese Government Businesswire
14-Aug-2023 Virpax Pharmaceuticals Reports 2023 Second Quarter Results and Recent Developments Businesswire
14-Aug-2023 FDA Accepts MyMD Pharmaceuticals’ Investigational New Drug Application (IND) for Phase 2 Study of oral TNF-α inhibitor MYMD-1® in Rheumatoid Arthritis (RA) Businesswire
14-Aug-2023 IGC Pharma Reports First Quarter Results; Company Continues to Make Significant Progress Advancing Its Lead Alzheimer’s Candidate Through Phase 2 Clinical Trials Businesswire
14-Aug-2023 U.S. FDA Approves First Therapeutic Indication for Revance’s DAXXIFY® (DaxibotulinumtoxinA-lanm) for Injection for the Treatment of Cervical Dystonia Businesswire
14-Aug-2023 Enveric Biosciences Reports Second Quarter 2023 Corporate and Financial Results Businesswire
14-Aug-2023 GE HealthCare Receives FDA Clearance for Portrait Mobile, A First-Of-Its-Kind, Wireless Monitoring Solution Aiding Early Detection of Patient Deterioration Businesswire
14-Aug-2023 Expanding Horizons: Global Oryzenin Market Poised for 14% CAGR Growth, Fueled by Rising Demand in Dairy Alternatives, Beverages, and More - ResearchAndMarkets.com Businesswire
14-Aug-2023 Promega and BTC Institute D.O.O.R.S Scholarship Recognizes STEM Students from Underrepresented Backgrounds Businesswire
14-Aug-2023 Antibe Reports Q1 2024 Interim Financial and Operating Results Businesswire
14-Aug-2023 Venatorx Pharmaceuticals Highlights Two Recent Publications Indicating Rising Metallo-Beta-Lactamases for Carbapenem-Resistant Enterobacterales in US Businesswire
14-Aug-2023 Zura Bio Reports Second Quarter 2023 Financial Results and Recent Business Highlights Businesswire
14-Aug-2023 TherapeuticsMD Announces Second Quarter 2023 Financial Results Businesswire
14-Aug-2023 GeneTex Addresses GPCR Targets With Its Recombinant Monoclonal Antibody Production Platform Newswire
14-Aug-2023 DurAVR™ THV Demonstrates Exceptional Results in Second Valve-in-Valve Case Businesswire
14-Aug-2023 Lactiga Receives FDA 'Rare Pediatric Disease' Designation for Groundbreaking Mucosal Immunoglobulin Therapy for Common Variable Immunodeficiency Disease Newswire
14-Aug-2023 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
11-Aug-2023 Revelation Biosciences Inc. Announces Financial Results for the Three and Six Months Ended June 30, 2023 Businesswire